Author

Robert John Hoyer

Observed names: R. Hoyer, R.J. Hoyer, Robert Hoyer, Robert J. Hoyer

Institutions: University of Colorado Health, Memorial Hospital

Observed institutions: National Institutes of Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Georgetown University Medical Center, University of Colorado Health, National Cancer Institute, Memorial Hospital, Georgetown Lombardi Comprehensive Cancer Center, University of Virginia, University of Colorado Colorado Springs

OpenAlex ID: A5113652639

Phase I Study in Advanced Cancer Patients of a Diversified Prime-and-Boost Vaccination Protocol Using Recombinant Vaccinia Virus and Recombinant Nonreplicating Avipox Virus to Elicit Anti–Carcinoembryonic Antigen Immune Responses

2000 · John L. Marshall, Robert J. Hoyer, et al. · Journal of Clinical Oncology · 357

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

2019 · J.M. Weiss, T. Csoszi, et al. · Annals of Oncology · 167

Treatment of diuretic refractory pleural effusions with bevacizumab in four patients with primary systemic amyloidosis

2007 · Robert J. Hoyer, Nelson Leung, et al. · American Journal of Hematology · 22

First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors

2025 · Daphne Day, Vinod Ganju, et al. · British Journal of Cancer · 9

Trilaciclib (G1T28): A cyclin dependent kinase 4/6 inhibitor, in combination with etoposide and carboplatin (EP) for extensive stage small cell lung cancer (ES-SCLC)—Phase 1b results.

2017 · Caio Max S. Rocha Lima, Patrick J. Roberts, et al. · Journal of Clinical Oncology · 9

Late onset aplastic anemia during treatment of chronic myeloid leukemia with imatinib mesylate

2006 · G. LeMarbre, C. Schinstock, et al. · Leukemia Research · 6

Complications after traction removal of direct percutaneous endoscopic jejunostomy: three case reports

2005 · Robert J. Hoyer, Amindra S. Arora, et al. · Gastrointestinal Endoscopy · 6

1028P Preliminary phase I results from a first-in-human study of EMB-02, a PD-1xLAG-3 bispecific antibody, in patients (pts) with advanced solid tumors

2023 · D. Day, V. Ganju, et al. · Annals of Oncology · 5

Phase II study of cabozantinib and nivolumab in refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC).

2025 · Alexis Diane Leal, Patrick Jud Blatchford, et al. · Journal of Clinical Oncology · 3

P1.07-002 G1T28, a Cyclin Dependent Kinase 4/6 Inhibitor, in Combination with Topotecan for Previously Treated Small Cell Lung Cancer: Preliminary Results

2017 · Lowell Hart, Patrick Roberts, et al. · Journal of Thoracic Oncology · 2

MA04.01 Non-Amplification Mutation of ERBB2 in EGFR-Mutated Lung Cancer

2017 · Kyle Gowen, Balazs Halmos, et al. · Journal of Thoracic Oncology · 2

456 A phase 1b/2 umbrella study of anti-PD-1 sasanlimab in combination with other therapies for patients with stage IIIB/IV non-small cell lung cancer (NSCLC): The LANDSCAPE 1011 trial in progress

2021 · Michael Boyer, Sandip Patel, et al. · Regular and Young Investigator Award Abstracts · 1

Trilaciclib (T) decreases multi-lineage myelosuppression in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy

2018 · K.H. Dragnev, T.K. Owonikoko, et al. · Annals of Oncology · 1

Phase II study of neoadjuvant FLOT and chemoradiation for trimodality therapy of esophageal/GEJ adenocarcinoma.

2025 · Jeffrey R. Olsen, Alexis Diane Leal, et al. · Journal of Clinical Oncology

Treatment of Diuretic Refractory Pleural Effusions with Bevacizumab in Four Patients with Primary Systemic Amyloidosis (AL).

2006 · Robert J. Hoyer, Nelson Leung, et al. · Blood

Complications After Traction Removal of Direct Percutaneous Endoscopic Jejunostomy (dpej)

2004 · Robert J. Hoyer, Amindra S. Arora, et al. · The American Journal of Gastroenterology

Works count: 16

Citation count: 590

H-index: 6

I10-index: 3